⭕Gracias al Observatorio de Cáncer de Pulmón sabemos el perfil de paciente▶ Pese a que el perfil del paciente con cáncer de pulmón en España es el de un varón, fumador, con edad media de 65 años, las mujeres ya representan 1 de cada 4 casos (el 27%). https://t.co/WPsNvhktu8

CLARIFY researchers publish an article that highlights the importance of including sexual health assessment in oncological patient follow-up: Sexual dysfunction in patients with cancer, a challenge in oncology practice: https://t.co/MzDAqtEjxZ

⭕The risk of dying from breast cancer within five years has fallen from 14% in the 1990s to 5% today, 👉according to research published in The British Medical Journal. #breastcancer #cancersurvivor https://t.co/Bj6UQ3CAQu

▶Lymphoma survivors need to be monitored for cancer recurrence and secondary cancer risks. 🗣Stay vigilant about your health and find support from others who have been through similar experiences. #lymphoma #cancersurvivor https://t.co/KGOJ4hMQdw

⭕The vast majority of women diagnosed with early stage breast cancer today can expect to become long-term survivors, not casualties of the disease, according to 👉research published in The British Medical Journal. #breastcancer #cancersurvivor https://t.co/Bj6UQ3CAQu

‼ For some women diagnosed with 👉early-stage breast cancer, the risk of death within five years is as low as 0.2%, according to a new study. #breastcancer #cancersurvivor https://t.co/s7ZSEy6f7d

▶A new prognostic model using real-life data can help predict survival beyond 🙌 24 months for advanced stage EGFR mutated non-small cell lung cancer patients. #lungcancer #cancersurvivor https://t.co/Jn8eXoe65F

⭕The conclusions of the study Sexual dysfunction in patients with lung cancer, from the ▶CLARIFY Project, were presented in Singapur at the IASLC 2023 by Dra Vanessa Ospina.

⭕Dr Virginia Calvo presented 👉Utility of Big Data and AI for exploring the role of genetic risk. ➡Family history of cancer and lung cancer, results of the CLARIFY Project in the IASLC 2023 in Singapour.

⭕Read more about sexual dysfunction in patients with cancer in this ▶new article published in Clin Transl Oncol by CLARIFY researcher Dr Vanessa Ospina https://t.co/MbsIV3Jasu

‼Immunotherapy provides long-term survival benefit for lung cancer patients,▶ according to new evidence presented at the European Lung Cancer Congress. #lungcancer #cancersurvivor https://t.co/UvxqxRJr4l

#4257: Asses🌱sment of healthy lifestyle habits in breast cancer patients 🏃‍♀️ #5463: METASTATIC BREAST CANCER: Variations in motor activity and sleep patterns based on treatment type. Join us at #ESMO2023 for groundbreaking revelations! 💪 #BreastCancerResearch #CircadianRhythms

Exciting news! 📊 The results of our analysis on breast cancer patients and circadian rhythms will be unveiled at ESMO in October 2023. Stay tuned for insights on: 🔬 #4208: SLEEP DISORDERS in early breast cancer over time 👇👇

🙌🙌Read about CLARIFY and the project achievements to develop 🗣a better approach to follow-up care https://t.co/lAFDDZ0Gl8

👉Most early-stage breast cancer patients will become long-term survivors, according to a UK study. 🗣The likelihood of death within five years was much lower for those diagnosed in the later part of the study. #breastcancer #cancersurvivor https://t.co/odoK6bwd53 "

Patients with lung cancer have high prevalence of sexual dysfunction related with oncological treatment. Follow-up strategies should be improved for specific support SD in this population. Results from CLARIFY project. Poster Session Real World data. @IASCL #WCLC23 @Clarify2020

Beyond the Valley of Death #workshop commencing now after the briefing on ongoing #cs_aiw #cluster activities. Collective discussions and plans for 2024 now activated. Pleased to explain the thinking for the advancement of the cluster. @Clarify2020, @MenhirH2020, @ascape_h2020

👉A new prognostic model using real-life data can help predict survival beyond 24 months for advanced stage🙌 EGFR mutated non-small cell lung cancer patients. #lungcancer #cancersurvivor https://t.co/n3rs3URMIV

📰📰📰The results of the analysis of breast cancer patients and Circadian rhythms will be presented at ESMO in October 2023. 🎇 We will keep you posted!

🙌More results of the CLARIFY Project in IASLC 2023: ⭕Utility of Big Data and AI for exploring the role of genetic risk. 📑Family history of cancer and lung cancer to be presented by @VirginiaCalvo6 in Singapour 📆ORAL Sunday, September 10, 2023 at 12:30 PM UTC +8